Mounjaro Cost in the UK: Pricing by Dose and How to Access It

How Much Does Mounjaro Cost in the UK?#

Mounjaro (tirzepatide) is available privately in the UK, with prices starting from around £136.88 per month at the starter dose. Costs rise as you move through the dose escalation schedule, reaching up to £268.88 per month at the maximum 15mg dose. Because Mounjaro is not yet routinely available on the NHS for most people in England, the majority of people accessing it are paying privately through registered pharmacies and online clinics.

Those are the headline numbers. But the actual cost of treatment over several months depends on how long you stay at each dose, whether you need monitoring tests, and which provider you choose. This article breaks all of that down clearly.

Mounjaro Pricing by Dose (4-Week Supply)#

Mounjaro follows a structured dose escalation. You start low, your body adjusts, and the dose increases gradually over several months. Each step up comes with a price increase. Here is how the pricing looks at Totiva, a GPhC-registered UK online pharmacy (registration 9012997):

The standard titration schedule means most people spend the first four weeks at 2.5mg, then move to 5mg, then 7.5mg, and so on. You don't have to rush to the maximum dose. Many people find a comfortable maintenance dose somewhere in the middle, and some stay there long-term rather than escalating further.

If you're planning ahead, a rough 12-month projection might look like this: two months at 2.5mg and 5mg (the titration phase), then six to eight months at a mid-range or higher maintenance dose. That puts a realistic annual spend somewhere in the region of £2,400 to £3,000 for most people, depending on where they stabilise.

What's Included in the Cost?#

At Totiva, the consultation is free. You complete a secure online health assessment, followed by a short video call with a clinician (this is a regulatory requirement for GLP-1 medications like Mounjaro, not just a formality). The video call typically takes around 10 to 15 minutes. You only pay for the medication itself after your prescription has been approved.

There is no subscription, no hidden setup fee, and no minimum commitment. If you want to pause or stop treatment, you can do so without penalty.

Some providers bundle additional services into their pricing, such as dietitian support or app-based coaching. These can add genuine value for people who want more structured lifestyle support alongside the medication. The trade-off is a higher monthly cost. At the pharmacy end of the market, you're paying for the medication and clinical oversight, which is generally the more affordable option.

One additional cost to factor in: some people choose to get baseline blood tests before starting, and periodic check-ins with their GP during treatment. These aren't mandatory when accessing Mounjaro privately, but they're sensible. A private blood panel typically costs £50 to £150 depending on what's included, and many GPs will do a basic metabolic check as part of routine care.

Is Mounjaro Available on the NHS?#

This is the question most people have, and the honest answer is: it depends, and the situation is evolving.

NICE approved tirzepatide (Mounjaro) for weight management in England in 2024 under Technology Appraisal TA1026. However, NHS access is being rolled out in phases through specialist weight management services, not through standard GP prescriptions. The phased rollout means that even if you meet the eligibility criteria on paper, your local Integrated Care Board (ICB) may not yet be funding it.

The NICE eligibility criteria for NHS access to Mounjaro include a BMI of 35 or above, at least one weight-related health condition (such as type 2 diabetes, hypertension, or sleep apnoea), and referral via a specialist weight management service (Tier 3 or above). People with a BMI of 30 to 34.9 may qualify with certain high-risk conditions.

For many people who meet these criteria, the realistic wait for NHS access could still be months or longer, depending on local service capacity. This is one reason why private access remains the practical route for those who want to start treatment now.

It's also worth clarifying one common misconception: Prescription Prepayment Certificates (PPCs) do not apply to private prescriptions. If you access Mounjaro privately, the PPC that covers NHS prescriptions will not reduce your cost.

Scotland, Wales, and Northern Ireland: NHS access through the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) follows different timelines and criteria from NICE guidance in England. If you're outside England and hoping for NHS access, it's worth checking current guidance from your nation's medicines body, as these processes are separate.

How Mounjaro Compares to Other Weight Loss Medications#

Mounjaro works differently from other GLP-1 medications like Wegovy (semaglutide) or Saxenda (liraglutide). It targets two hormonal pathways: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism is why clinical trial results for tirzepatide have generally shown greater average weight loss than semaglutide alone.

The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, found that participants taking the highest dose of tirzepatide lost up to 22.5% of their body weight over 72 weeks. That's a significant figure, though individual results vary considerably based on diet, activity, and adherence.

Here's a quick comparison of the main options currently available:

Mounjaro (tirzepatide): Dual GLP-1/GIP agonist. Average weight loss 15 to 22.5% in trials. Weekly injection. Starts from £136.88/month at Totiva.

Wegovy (semaglutide): GLP-1 agonist. Average weight loss 12 to 15% in trials. Weekly injection. Available at Totiva from £92.88/month at starter doses.

Wegovy tablets (oral semaglutide): The same active ingredient as the injection, in once-daily tablet form. Average weight loss around 17% in trials. Available at Totiva from £99/month. A good option for people who prefer not to inject.

Saxenda (liraglutide): Older GLP-1 agonist, daily injection. Average weight loss 5 to 10%. Less commonly used now that newer options are available.

Orlistat: Blocks fat absorption. Modest weight loss of around 3 to 5%. Cheapest option but significantly less effective.

The higher cost of Mounjaro relative to Wegovy or orlistat generally reflects the stronger clinical evidence for greater weight loss. Whether that difference justifies the extra monthly spend is a personal decision that depends on your health goals, your starting weight, and what your clinician recommends.

You can explore all of Totiva's weight loss treatment options on the weight loss service page.

Who Is Eligible for Mounjaro Privately?#

Private eligibility criteria are set by the prescribing clinician, not by NICE, so they're slightly more flexible than NHS criteria. As a general guide, most UK online pharmacies and clinics will prescribe Mounjaro to adults who:

• Have a BMI of 30 or above (obesity), or
• Have a BMI of 27 or above with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnoea
• Are aged 18 to 74
• Have no contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
• Are not pregnant or breastfeeding

At Totiva, a clinician reviews your health questionnaire and conducts a short video consultation before approving any prescription. This isn't just a box-ticking exercise. It's the process that ensures Mounjaro is genuinely appropriate for you, and that the starting dose is right.

What Happens If You Stop Taking Mounjaro?#

This is an important question that doesn't always get a straight answer. The clinical evidence is reasonably clear: most people regain a significant portion of the weight they lost when they stop taking tirzepatide, particularly if lifestyle changes haven't been embedded alongside the medication.

A 2022 study published in Nature Medicine found that participants who discontinued tirzepatide regained most of their lost weight within a year of stopping. This isn't unique to Mounjaro. It reflects the underlying biology of obesity as a chronic condition rather than a character flaw or lack of willpower.

This has two practical implications for cost planning. First, Mounjaro is likely to be a longer-term commitment for people who want to maintain results. Second, using the medication as a window to build healthier eating habits and activity patterns gives you the best chance of holding onto some of the benefit after stopping.

Some people do step down to a lower maintenance dose rather than stopping entirely, which reduces monthly cost while maintaining some appetite regulation.

How to Get Mounjaro Through an Online Pharmacy#

The process through Totiva is straightforward. You start by completing a free online health questionnaire, then have a short video consultation with a clinician. If Mounjaro is suitable for you, a prescription is issued and your medication is dispensed and shipped to your door. You pay only after approval.

There's no subscription to sign up for and no obligation to continue if you decide it's not right for you. Totiva is a GPhC-registered pharmacy operating entirely within the UK regulatory framework, so all prescriptions are issued by qualified UK clinicians and all medications are sourced through licensed supply chains.

If you're ready to find out whether Mounjaro is suitable for you, you can start a free weight loss consultation at Totiva. The process typically takes around 10 to 15 minutes, and you'll have a clinician response within 24 hours.

The True Cost of Mounjaro: A Realistic Summary#

Here's a clear-eyed view of what private Mounjaro treatment actually costs over time:

• Consultation: Free at Totiva
• Starter dose (2.5mg, month 1): £136.88
• Titration phase (months 1 to 3, approximate): £136.88 to £207.88/month
• Mid-range maintenance (7.5mg to 10mg): £207.88 to £232.88/month
• Higher maintenance (12.5mg to 15mg): £248.88 to £268.88/month
• Optional blood tests: £50 to £150 (private, one-off or periodic)

Over 12 months, assuming a gradual escalation and a mid-to-high maintenance dose, you're realistically looking at £2,200 to £2,900 depending on your individual escalation pattern. That's a meaningful investment, and it's worth having that conversation with your clinician about realistic expectations and timelines before you begin.